Fig. 2From: Survival outcome of different treatment sequences in patients with locally advanced and metastatic pancreatic cancerSubgroup analysis by forest plot, with HRs for OS, in the patients treated with B line and C line. Abbreviations: ECOG, Eastern Cooperative Oncology Group performance scale; B line, NabP combined therapy to Gem combined therapy to FOLFIRINOX; C line, NabP combined therapy to Gem combined therapy to oxaliplatin or irinotecan combined therapyBack to article page